Scrutiny of SAS-B data for psychiatric conditions exposes prescribing ‘disconnect’ by Steve Jones June 7, 2023June 7, 2023 Patients are being prescribed medicinal cannabis for psychiatric conditions where evidence is lacking or unclear, in […]
Gender bias and medicinal cannabis research: where do we go from here? by Hannah Adler June 16, 2022June 16, 2022
Flower prescriptions for anxiety growing despite lack of evidence, according to new Lambert study by Martin Lane May 10, 2022May 10, 2022
Meet the women blazing a trail in cannabis research by Hannah Adler December 16, 2021December 22, 2021
Australian Rheumatology Association calls for more evidence on cannabis by Hannah Adler December 15, 2021December 16, 2021